Ricardo Mancebo is Founder & CEO of GenEndeavor, a molecular diagnostics technology tools company on a mission to prevent genetic and infectious disease progression by quickly and accurately detecting pathological biomarkers in early stages. He has worked for over 20 years in the San Francisco Bay Area developing cutting-edge genomics technologies and products in the biotech industry. Ricardo founded GenEndeavor to develop a new generation of non-enzymatic assay technology platforms to address major gaps in healthcare. His mission is to empower very early screening of genetic and infectious diseases while they are still treatable, and to enable rapid POC testing at a cost that is orders of magnitude lower than current enzyme-based technologies.